pfizer glp-1 news scraps daily weight loss pill danuglipron after a liver injury Pfizer Enters China GLP-1 Market

But it wasnt until semaglutide hit the market (first as Ozempic [archived link] in 2017 followed by Wegovy [archived link]) in 2021) that GLP-1 RAs captured the worlds attention

This combination of effects makes it easier for you to stick to a reduced-calorie diet and, in turn, achieve significant and sustained weight loss

doi:10.3928/01477447-20151222-12 Carender CN, Glass NA, DeMik DE, Elkins JM, Brown TS, Bedard NA

found that 52 weeks of once-weekly semaglutide (the active ingredient in Ozempic and Wegovy) reduced hip bone mineral density by 2.6% and lumbar spine density by 2.1% compared to placebo in adults with increased fracture risk